Showing results (241-250 of 303) with videos related to
Sort By:
Pageof 31
Journal of the American Medical Directors Association|June 5, 2021
Uncontrolled Pain and Risk for Depression and Behavioral Symptoms in Residents With DementiaYu-Jung Jenny Wei, Cheng Chen, Roger B Fillingim, et al.Pharmacoepidemiology and Drug Safety|September 10, 2020
Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancyYanmin Zhu, Christian Hampp, Xi Wang, et al.Epidemiology (Cambridge, Mass.)|November 16, 2020
A Pharmacoepidemiologic Approach to Evaluate Real-world Effectiveness of Hormonal Contraceptives in the Presence of Drug-drug InteractionsAmir Sarayani, Joshua D Brown, Amie J Goodin, et al.American Journal of Epidemiology|March 18, 2026
A new tool for pregnancy research: a unified definition for major congenital malformation across ICD erasThuy N Thai, Nicole E Smolinski, Sonja A Rasmussen, et al.American Journal of Epidemiology|June 11, 2026
PEPRVision: a visualization framework for Pharmacoepidemiology researchYanning Wang, Hung-Kai Chen, Wen Wen, et al.The British Journal of Dermatology|September 6, 2019
An osteopontin-derived peptide inhibits human hair growth at least in part by decreasing fibroblast growth factor-7 production in outer root sheath keratinocytesM Alam, M Bertolini, J Gherardini, et al.American Journal of Obstetrics and Gynecology|January 15, 2022
Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation StrategiesAmir Sarayani, Yasser Albogami, Thuy Nhu Thai, et al.Diabetes Care|December 4, 2023
Associations Between Postdischarge Care and Cognitive Impairment-Related Hospital Readmissions for Ketoacidosis and Severe Hypoglycemia in Adults With DiabetesYehua Wang, Tianze Jiao, Matthew R Muschett, et al.Drug Safety|February 14, 2024
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic StudyMonica A Muñoz, Gerald J Dal Pan, Yu-Jung Jenny Wei, et al.Pharmacotherapy|September 4, 2019
Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug AdministrationMonica A Muñoz, Chris Delcher, Gerald J Dal Pan, et al.Pageof 31